With its stock down 7.1% over the past month, it is easy to disregard Gerresheimer (ETR:GXI). However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Gerresheimer (0NTI – Research Report), with a price ...

Deutsche Bank analyst Falko Friedrichs maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of ...

A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to ...

The potential acquisition comes as Gerresheimer AG, known for producing pens for injectable weight loss drugs like Wegovy, has been in preliminary talks with private equity investors regarding a sale.

FRANKFURT/NEW YORK (Reuters) -A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer ...

A group comprising private equity companies Warburg Pincus and KKR is reportedly in discussions to acquire Gerresheimer, a German company specialising in packaging for medicines and beauty products.

Gerresheimer has a market value of about €2.7 billion German firm has attracted interest from multiple buyout firms The private equity firms emerged as the frontrunner after they teamed up and other ...

(Bloomberg) -- A consortium consisting of Warburg Pincus and KKR & Co. are in talks to acquire Gerresheimer AG, the German maker of packaging for drugs and cosmetics, according to people familiar with ...

A consortium of private equity firms including Warburg Pincus and KKR & Co. (KKR) are in advanced discussions to buy Gerresheimer AG (OTCPK:GRRMF). The PE funds are now the leaders to purchase the ...

A consortium consisting of Warburg Pincus and KKR are in talks to acquire German medical packaging maker Gerresheimer AG , Bloomberg News reported on Wednesday citing people familiar with the matter.

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics ...